The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Evidence in Practice

Wednesday, 10 October 2018
A recent study from Finland shows that children with serum 25-hydroxyvitamin D levels >80 nmol/l had lower plasma total and LDL cholesterol levels than children whose serum 25-hydroxyvitamin D levels were
Wednesday, 10 October 2018
People that sleep for more than 8 hours a night have a greater mortality and cardiovascular risk than those who sleep for under seven hours, according to a recent systematic review published in the Journal of the American Heart Association. The study also found that a sleep duration of 10 hours is linked with a 30% increased mortality risk compared to sleeping for seven hours.
Wednesday, 10 October 2018
The most extensive systematic assessment of effects of omega‐3 fats on cardiovascular health to date suggests that increasing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) has little or no effect on mortality or cardiovascular health.
Tuesday, 25 September 2018
A new study supports the growing body of evidence showing that consumption of full-fat milk, yoghurt, cheese and butter does not increase heart disease, stroke or overall mortality in older adults. The study also suggested that increased levels of one fatty acid may actually lower the risk of stroke.
Topics covered:
Tuesday, 25 September 2018
The recent TRANSITION study shows that sacubitril/valsartan can be initiated early and safely in a wide range of heart failure (HF) patients with reduced ejection fraction (HFrEF) who have been stabilized after hospitalization due to an acute HF episode. Patients involved in the study included those with no prior experience of sacubitril/valsartan or conventional HF therapies, as well as those with prior experience of conventional HF therapies.
Topics covered:
Tuesday, 25 September 2018
The large randomised controlled ASCEND trial (n=15,480) shows that aspirin reduced the risk of serious vascular events in people with diabetes and no CVD by 12% but also increased the risk of major bleeding by 29% and the authors concluded that absolute benefits were outweighed by bleeding hazard. The trial suggests that aspirin should not be used for primary prevention in patients with diabetes
Topics covered:
Thursday, 16 August 2018
Increased physical activity, not weight loss, gives individuals with coronary heart disease (CHD) including angina and myocardial infarction a longer lifespan, according to a new long-term Norwegian study.
Thursday, 16 August 2018
A new study shows that medicines effective in treating type 2 diabetes in adults do not slow disease progression in young people. The researchers commented that this is a disturbing finding as type 2 diabetes among young is a growing problem.
Topics covered:
Page 1 of 5

Article search and filter